Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies - Trial NCT06229236
Access comprehensive clinical trial information for NCT06229236 through Pure Global AI's free database. This phase not specified trial is sponsored by Johns Hopkins University and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 148 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Johns Hopkins University
Timeline & Enrollment
N/A
Feb 13, 2024
Jun 30, 2026
Primary Outcome
Percent of participants whose Diabetes Technology Utilization Score (DTUS) increases (based on review of last 14 days of CGM and insulin pump data)
Summary
The goal of this randomized control trial is to determine if the support of a Diabetes
 Navigator is more effective than standard care in improving uptake and use of advanced
 diabetes technology among patients with type 1 diabetes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06229236
Non-Device Trial